Harvard Breast Cancer 2023: New Horizons, Current Controversies covers all elements of breast cancer care. Discuss disease mechanisms, diagnostic advances, innovative treatments, and breast cancer survivors’ complete care in Harvard Breast Cancer 2023.
Lesson Objectives for Harvard Breast Cancer 2023:
Participant skills after Harvard Breast Cancer 2023 include:
- Select advanced breast cancer patients for novel therapy using current clinical data and expert advice.
- Use knowledge in treating breast cancer in old and young women to customize treatment programs.
- Use appropriate risk assessment methodologies and make educated therapeutic decisions for women who may benefit from neoadjuvant or adjuvant therapy. Understand genomic testing limitations.
- Use current clinical data and professional advice to treat mastectomy-affected breast cancer patients. This involves discussing surgical procedures, breast reconstruction, and post-mastectomy radiation therapy.
- Assess symptom management during treatment and survivorship, as well as fertility and lifestyle advice for breast cancer survivors. Enhance current practices if necessary.
- Assess genetic and personal risk factors for breast cancer and use appropriate genetic testing procedures to detect hereditary breast cancer.
schedule for Harvard Breast Cancer 2023:
Thursday, July 20, 2023
- 8:00-8:15 AM
Welcoming Remarks
Harold Burstein, MD, PhD
SESSION I BREAST SURGERY
- 8:15-8:35 AM
Management Of the Axilla
Monica Morrow, MD
- 8:35-8:55 AM
construction Options In 2023
Matthew Carty, MD
- 8:55-9:15 AM
Lymphatic Surgery
Michelle Coriddi, MD
- 9:15-9:30 AM
Q&A
- 9:30-9:55 AM
Lecture: The Future Of Breast Cancer Pathology
Jorge Reis-Filho, MD, PhD, FRCPath
- 9:55-10:10 AM
Q&A
- 10:10-10:25 AM
Break
SESSION II GENETICS
- 10:25-10:45 AM
Prophylactic Surgery: Who, What, When?
Barbara Smith, MD, PhD
- 10:45-11:05 AM
Genetic Testing: Who, Which Test, When?
Judy Garber, MD, MPH
- 11:05-11:30 AM
Managing Hereditary Breast Cancer: What We Do; What We Still Don’t Know
Nadine Tung, MD
- 11:30-11:45 AM
Q&A
- 11:45 AM-1:00 PM
Lunch
*not provided
- 1:00-1:25 PM
Lecture: The Future Of Breast Cancer Imaging And Screening
Constance Lehman, MD, PhD
- 1:25-1:40 PM
Q&A
SESSION III RADIATION THERAPY
- 1:40-2:00 PM
Schedules And Regimens
Jennifer Bellon, MD
- 2:00-2:20 PM
Postmastectomy Radiation
Rachel Jimenez, MD
- 2:20-2:40 PM
Oligometastatic Disease
Steven Chmura, MD, PhD
- 2:40-3:00 PM
Radiotherapy Options for Brain Metastases
Ayal Aizer, MD, MHS
- 3:00-3:15 PM
Q&A
- 3:15-3:30 PM
Break
- 3:30-3:55 PM
Lecture: The Future Of Breast Cancer: Radiation Oncology
Bruce Haffty, MD, MS
- 3:55-4:10 PM
Q&A
- 4:10-5:10 PM
Tumor Board: Local Regional Therapy
Tari King, MD, FACS
Friday, July 21, 2023
SESSION IV ER POSITIVE BREAST CANCER
- 8:00-8:20 AM
Novel Agents: SERDS
Rinath Jeselsohn, MD
- 8:20-8:40 AM
Novel Agents: AKT Pathways
Alex Toker, PhD
- 8:40-9:00 AM
Male Breast Cancer
Jose Pablo Leone, MD
- 9:00-9:20 AM
Role Of ADCs In ER+ Breast Cancer
Paolo Tarantino, MD
- 9:20-9:40 AM
Special Considerations in Premenopausal Women
Erica Mayer, MD, MPH
- 9:40-9:55 AM
Break
- 9:55-10:15 AM
Adjuvant Endocrine Therapy: How Long?
Heather Parsons, MD, MPH
- 10:15-10:35 AM
Adjuvant Therapy: CDK4/6 Inhibitors
Sarah Sammons, MD
- 10:35-10:55 AM
Adjuvant Therapy: Chemotherapy
Beverly Moy, MD, MPH
- 10:55-11:20 AM
Local Regional Considerations in Older Cancer Patients
Christina Minami, MD
- 11:20-11:35 AM
Q&A
- 11:35 AM-12:00 PM
Lecture: The Future of Breast Cancer Clinical Trials Designs
Nabihah Tayob, PhD
- 12:00-12:10 PM
Q&A
- 12:10-12:30 PM
Break
- 12:30-1:35 PM
Tumor Board: Advanced Breast Cancer
Moderator:Â Erica Mayer, MD, MPH
*Lunch Included
- 1:35-1:45 PM
Break
SESSION V TRIPLE-NEGATIVE BREAST CANCER
- 1:45-2:05 PM
Where To with Immunotherapy
Sara Tolaney, MD, MPH
- 2:05- 2:25 PM
Treating Brain Metastases
Nancy Lin, MD
- 2:25-2:45 PM
Antibody Drug Conjugates
Aditya Bardia, MD, MPH
- 2:45-3:10 PM
Lecture:Â The Future of Immunotherapy In Breast Cancer
Elizabeth Mittendorf, MD, PhD
- 3:10-3:20 PM
Q&A
Sara Tolaney, MD, MPH
Nancy Lin, MD
Aditya Bardia, MD, MPH
Elizabeth Mittendorf, MD, PhD
- 3:20-3:35 PM
Break
SESSION VI SURVIVORSHIP
- 3:35-3:55 PM
Pregnancy After Breast Cancer
Ann Partridge, MD, MPH
- 3:55-4:15 PM
Cannabinoids And Breast Cancer
Ilana Braun, MD
- 4:15-4:35 PM
Exercise, Diet And Breast Cancer
Jennifer Ligibel, MD
- 4:35-4:45 PM
Q&A
Ann Partridge, MD, MPH
Ilana Braun, MD
Jennifer Ligibel, MD
- 4:45-5:10 PM
Schlager Lecture: The Future Of Breast Cancer And Genomic Tools And Testing
Fabrice Andre, MD, PhD
- 5:10-5:20 PM
Q&A
Saturday, July 22, 2023
TUMOR BOARD
- 8:00 – 9:00 AM
Tumor Board: Early-Stage Breast Cancer
Hal Burstein, MD, PhD
- 9:00 – 9:30 AM
ASCO Highlights
Harold Burstein, MD, PhD
- 9:30 – 9:45 AM
Break
SESSION VII HER2 POSITIVE BREAST CANCER
- 9:45 – 10:05 AM
ADCs For HER2 Positive Tumors
Rachel Occhiogrosso Abelman, MD
- 10:05 – 10:25 AM
HER2 Testing
Laura Collins, MD
- 10:25 – 10:45 AM
Treatment For Early-Stage HER2 Positive Breast Cancer
Adrienne Waks, MD
- 10:45 -11:05 AM
Curing HER2+ Breast Cancer
Steven Isakoff, MD, PhD
- 11:05 – 11:20 AM
Q&A
- 11:20 -11:30 AM
See Also: New Vistas In Prostate Cancer Imaging 2022 (53 Videos)
Reviews
There are no reviews yet.